Functional Comparison between Endogenous and Synthetic Notch Systems.
EGF repeats
Notch signaling
endocytosis
membrane proteins
synNotch
trans-endocytosis
Journal
ACS synthetic biology
ISSN: 2161-5063
Titre abrégé: ACS Synth Biol
Pays: United States
ID NLM: 101575075
Informations de publication
Date de publication:
21 10 2022
21 10 2022
Historique:
pubmed:
16
9
2022
medline:
25
10
2022
entrez:
15
9
2022
Statut:
ppublish
Résumé
The Notch pathway converts receptor-ligand interactions at the cell surface into a transcriptional response in the receiver cell. In recent years, synthetic Notch systems (synNotch) that respond to different inputs and transduce different transcriptional responses have been engineered. One class of synNotch systems uses antibody-antigen interactions at the cell surface to induce the proteolytic cleavage cascade of the endogenous Notch autoregulatory core and the consequent release of a synNotch intracellular domain (ICD), converting surface antigen detection into a cellular response. While the activation of endogenous Notch requires ubiquitylation and subsequent endocytosis of the ligand ICD, these synNotch systems do not seem to have such a requirement because the synNotch ligands completely lack an ICD. This observation raises questions about existing models for the synNotch activation mechanism. Here, we test how different structural and biochemical factors affect the dependence of endogenous and synthetic Notch activation on ligand ICD. We compare the behavior of antibody-antigen synNotch (aa-synNotch) to that of endogenous Notch, and to a synNotch system that uses rapamycin induced dimerization of FK506 binding protein (FKBP) and FKBP rapamycin binding (FRB) domaindimerization domains (ff-synNotch), which still requires a ligand ICD. We found that differences in receptor-ligand affinity, in the identity of the transmembrane domain, or in the presence or absence of extracellular epidermal growth factor repeats cannot explain the differences in ligand ICD requirement that distinguishes aa-synNotch from endogenous Notch or ff-synNotch. We also found that unlike endogenous Notch and ff-synNotch, the aa-synNotch system does not exhibit trans-endocytosis of the receptor extracellular domain into the sender cell. These findings suggest that the aa-synNotch systems bypass the ligand ICD requirement because antigen-antibody pairs are able to promote other adhesive cell-cell interactions that provide the mechanical tension needed for ligand activation.
Identifiants
pubmed: 36107643
doi: 10.1021/acssynbio.2c00247
pmc: PMC9594772
doi:
Substances chimiques
Ligands
0
Epidermal Growth Factor
62229-50-9
Tacrolimus Binding Proteins
EC 5.2.1.-
Sirolimus
W36ZG6FT64
Antigens, Surface
0
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, U.S. Gov't, Non-P.H.S.
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
3343-3353Subventions
Organisme : NCI NIH HHS
ID : R35 CA220340
Pays : United States
Organisme : NIGMS NIH HHS
ID : R35 GM133482
Pays : United States
Références
Dev Cell. 2017 Mar 13;40(5):505-511.e6
pubmed: 28292428
Proc Natl Acad Sci U S A. 2018 Sep 4;115(36):E8395-E8402
pubmed: 30127001
PLoS Genet. 2015 Jun 26;11(6):e1005328
pubmed: 26114479
Cell. 2016 Feb 11;164(4):780-91
pubmed: 26830878
J Cell Sci. 2017 Nov 15;130(22):3829-3838
pubmed: 28972131
J Cell Biol. 2011 Dec 12;195(6):1017-31
pubmed: 22162135
Oncogene. 2008 Sep 1;27(38):5148-67
pubmed: 18758484
Elife. 2020 Oct 07;9:
pubmed: 33025906
Cell Rep. 2016 Jan 12;14(2):225-33
pubmed: 26748704
Science. 2017 Mar 24;355(6331):1320-1324
pubmed: 28254785
J Am Chem Soc. 2005 Apr 6;127(13):4715-21
pubmed: 15796538
Development. 2007 Feb;134(4):801-11
pubmed: 17229764
J Immunol. 2008 May 15;180(10):7028-38
pubmed: 18453625
Annu Rev Biophys. 2021 May 6;50:157-189
pubmed: 33534608
Semin Cell Dev Biol. 2012 Jun;23(4):473-80
pubmed: 22373641
Annu Rev Pathol. 2008;3:587-613
pubmed: 18039126
Elife. 2017 Sep 29;6:
pubmed: 28960177
Semin Cell Dev Biol. 2012 Jun;23(4):429-36
pubmed: 22306180
Dev Cell. 2012 Jun 12;22(6):1299-312
pubmed: 22658936
J Neurosci Res. 2002 Jun 15;68(6):655-67
pubmed: 12111827
Cell. 2017 Nov 30;171(6):1383-1396.e12
pubmed: 29195077
EMBO J. 2002 Feb 1;21(3):294-302
pubmed: 11823422
Sci Transl Med. 2021 Apr 28;13(591):
pubmed: 33910979
Science. 2015 Feb 20;347(6224):847-53
pubmed: 25700513
Cell. 2018 Feb 8;172(4):869-880.e19
pubmed: 29398116
Science. 2020 Oct 16;370(6514):327-331
pubmed: 33060357
Cell. 2022 Apr 14;185(8):1431-1443.e16
pubmed: 35427499
Proc Natl Acad Sci U S A. 2008 Aug 12;105(32):11212-7
pubmed: 18676613
J Cell Biol. 2007 Feb 12;176(4):445-58
pubmed: 17296795
J Cancer. 2021 Jan 1;12(2):326-334
pubmed: 33391429
Dev Cell. 2011 Jul 19;21(1):134-44
pubmed: 21763614
Cell. 2017 Mar 23;169(1):108-119.e20
pubmed: 28340336
J Biol Chem. 2013 Aug 30;288(35):25477-25489
pubmed: 23839946
Clin Transl Oncol. 2021 Jun;23(6):1003-1019
pubmed: 32997278
Dev Cell. 2015 Jun 22;33(6):729-36
pubmed: 26051539